Latest News

AstraZeneca COVID-19 vaccine trial volunteer has died, Brazil health authority says

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.

Posted on 21 October 2020 | 1:15 pm

Brazil's Bolsonaro says his government will not buy China's Sinovac vaccine

Brazil's President Jair Bolsonaro said on Wednesday that his government will not buy China's Sinovac vaccine against COVID-19, one day after the health minister said it would be included in the nation's immunization program.

Posted on 21 October 2020 | 8:37 am

Breakingviews - Corona Capital: U.S. state budget woes

NEW YORK/LONDON/HONG KONG/ZURICH (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Posted on 20 October 2020 | 4:11 pm

China's Sinovac vaccine to be included in Brazil's immunization program, governors say

The Brazilian government will include China's Sinovac vaccine against COVID-19 in its national immunization program, state governors said on Tuesday after a meeting with the country's health minister, in addition to one developed by AstraZeneca and Oxford University.

Posted on 20 October 2020 | 4:04 pm

China's Sinovac vaccine to be included in Brazil's immunization program, governors say

The Brazilian government will include China's Sinovac vaccine against COVID-19 in its national immunization program, state governors said on Tuesday after a meeting with the country's health minister, in addition to the vaccine developed by AstraZeneca and Oxford University.

Posted on 20 October 2020 | 3:20 pm

Breakingviews - Corona Capital: Procter & Gamble, Pay perks

NEW YORK/LONDON/HONG KONG/ZURICH (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Posted on 20 October 2020 | 11:23 am

Breakingviews - Corona Capital: Vaccines, Sex, Computers, Gardens

HONG KONG/ZURICH/LONDON (Reuters Breakingviews) - Corona Capital is a column updated throughout the day by Breakingviews columnists around the world with short, sharp pandemic-related insights.

Posted on 20 October 2020 | 6:05 am

Brazil's Butantan says tests show vaccine by China's Sinovac is safe

An experimental vaccine developed by China's Sinovac Biotech appeared to be safe in providing protection against the COVID-19 disease caused by the new coronavirus, preliminary results of a late stage clinical trial conducted in Brazil showed on Monday.

Posted on 19 October 2020 | 12:40 pm

Sinovac coronavirus vaccine offered by Chinese city for emergency use costs $60

A Chinese city is offering Sinovac Biotech's experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme for about $60.

Posted on 16 October 2020 | 2:45 am

Philippines eyes Sinovac trial as early as November

Sinovac Biotech may start late-stage trials of its coronavirus vaccine in the Philippines as early as next month, its food and drugs agency chief said on Thursday, after it hurdled the initial stage of the country's screening process.

Posted on 15 October 2020 | 3:14 am

SVA Basic Data

Shares Outstanding Shares Float
Short Float Short(Days to Cover)
Institution ownership Inst. 3 month change
Insider ownership Insider ownership
Average Volume Average True Range
Earnings Date Cash Per Share
EPS 12 mo. Trailing RSI

Trading Halts

Sinovac Biotech, Ltd Ord Shrs (SVA) is currently halted and it was halted at 02/22/2019 04:02 PM and has been halted 1 times today and 1 times the last 30 days and
Here are the 1 recent halts.
HaltDate Resume Date Reason Code
02/22/2019 04:02 PM T12

Available to Short


Number of shares available to short and the annual rate it costs to keep it short.
Avail Date Avail. Shares Fee rate in Annual %
10/23/2020 55000 2.53
10/22/2020 55000 2.53
10/21/2020 65000 2.53
10/20/2020 55000 2.53
10/19/2020 65000 2.53